XML 40 R25.htm IDEA: XBRL DOCUMENT
v3.25.1

Income Taxes | 12 Months Ended
--- | ---
Mar. 31, 2025
Income Taxes [Abstract] |
Income Taxes | 17. Income Taxes Domestic and foreign components of (loss) income before income taxes are as follows:
|  | Years Ended March 31,
|  |  | 2025 |  |  |  | 2024 |  |  |  | 2023 |
Domestic and foreign components of (loss) income |  |  |  |  |  |  |  |
United States |  | $ | (21,526,000 | ) |  | $ | (29,661,000 | ) |  | $ | (14,470,000 | )
Foreign |  |  | 5,839,000 |  |  |  | 16,593,000 |  |  |  | 11,361,000 |
Loss before income taxes |  |  | (15,687,000 | ) |  |  | (13,068,000 | ) |  |  | (3,109,000 | )
The income tax expense is as follows:
|  | Years Ended March 31,
|  |  | 2025 |  |  |  | 2024 |  |  |  | 2023 |
Current tax expense |  |  |  |  |  |  |  |  |  |  |  |
Federal |  | $ | 1,177,000 |  |  | $ | 1,696,000 |  |  | $ | 2,483,000 |
State |  |  | 631,000 |  |  |  | 363,000 |  |  |  | 396,000 |
Foreign |  |  | 3,780,000 |  |  |  | 4,553,000 |  |  |  | 3,426,000 |
Total current tax expense |  |  | 5,588,000 |  |  |  | 6,612,000 |  |  |  | 6,305,000 |
Deferred tax (benefit) expense |  |  |  |  |  |  |  |  |  |  |  |
Federal |  |  | (171,000 | ) |  |  | 25,320,000 |  |  |  | (5,037,000 | )
State |  |  | (28,000 | ) |  |  | 4,249,000 |  |  |  | (705,000 | )
Foreign |  |  | (1,606,000 | ) |  |  | (5,000 | ) |  |  | 535,000 |
Total deferred tax (benefit) expense |  |  | (1,805,000 | ) |  |  | 29,564,000 |  |  |  | (5,207,000 | )
Total income tax expense |  | $ | 3,783,000 |  |  | $ | 36,176,000 |  |  | $ | 1,098,000 |
Deferred income taxes consist of the following:
|  |  | March 31, 2025 |  |  |  | March 31, 2024 |
Assets |  |  |  |  |  |  |  |
Allowance for bad debts |  | $ | 48,000 |  |  | $ | 44,000 |
Customer allowances earned |  |  | 3,794,000 |  |  |  | 4,706,000 |
Allowance for stock adjustment returns |  |  | 3,344,000 |  |  |  | 3,620,000 |
Inventory adjustments |  |  | 8,497,000 |  |  |  | 7,419,000 |
Intangibles, net |  |  | 729,000 |  |  |  | 852,000 |
Stock options |  |  | 2,561,000 |  |  |  | 2,723,000 |
Operating lease liabilities |  |  | 19,333,000 |  |  |  | 21,251,000 |
Estimate for returns |  |  | 30,341,000 |  |  |  | 29,942,000 |
Accrued compensation |  |  | 2,585,000 |  |  |  | 2,600,000 |
Net operating losses |  |  | 3,426,000 |  |  |  | 4,670,000 |
Tax credits |  |  | 2,857,000 |  |  |  | 2,054,000 |
Capitalized research credits |  |  | 1,147,000 |  |  |  | 1,158,000 |
Plant and equipment, net |  |  | 1,460,000 |  |  |  | 1,010,000 |
Other |  |  | 4,639,000 |  |  |  | 6,588,000 |
Total deferred tax assets |  | $ | 84,761,000 |  |  | $ | 88,637,000 |
Liabilities |  |  |  |  |  |  |  |
Contract assets |  |  | (9,020,000 | ) |  |  | (10,265,000 | )
Operating lease assets |  |  | (16,848,000 | ) |  |  | (23,845,000 | )
Other |  |  | (2,453,000 | ) |  |  | (6,663,000 | )
Total deferred tax liabilities |  | $ | (28,321,000 | ) |  | $ | (40,773,000 | )
Less: valuation allowance |  | $ | (52,233,000 | ) |  | $ | (45,399,000 | )
Total deferred taxes |  | $ | 4,207,000 |  |  | $ | 2,465,000 |
As of March 31, 2025, before tax effect, the Company had federal net operating loss carryforwards of $1,694,000, state net operating loss carryforwards of $166,000 and foreign net operating loss carryforwards of $11,610,000. The federal net operating loss carryforwards expire beginning in fiscal year 2034, the state net operating loss carryforwards expire beginning in fiscal year 2032, and the foreign net operating loss carryforwards expire beginning in fiscal year 2038. As of March 31, 2025, the Company also had non-US tax credit carryforwards of $2,857,000, which will expire beginning in fiscal year 2034. Realization of deferred tax assets is dependent upon the Company’s ability to generate sufficient future taxable income. Significant judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities and any valuation allowance recorded against the Company’s net deferred tax assets. The Company makes these estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s future plans. A valuation allowance is established when the Company believes it is not more likely than not all or some deferred tax assets will be realized. In evaluating the Company’s ability to recover deferred tax assets within the jurisdiction in which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, past financial performance, and tax planning strategies. The net increase in the valuation allowance was $6,834,000 during the year ended March 31, 2025. This net increase in the valuation allowance is primarily due to the increase in the Company’s U.S. federal and various state deferred tax assets and the establishment of a valuation allowance on one of its Mexican subsidiaries partially offset by the reversal of the valuation allowance of one of its Canadian subsidiary’s deferred tax assets. The Company will continue to monitor its position in future periods. Should the actual amount differ from the Company’s estimates, the amount of any valuation allowance could be impacted. For the years ended March 31, 2025, 2024, and 2023, the primary components of the Company’s income tax expense were (i) federal income taxes, (ii) state income taxes, (iii) change in realizable deferred tax items, (iv) foreign income taxed at rates that are different from the federal statutory rate, and (v) impact of the non-deductible executive compensation under Internal Revenue Code Section 162(m). In addition, for the years ended March 31, 2025 and 2024, the Company’s income tax expense included the impact of an excess tax benefit from share-based compensation. The difference between the income tax expense at the federal statutory rate and the Company’s effective tax rate is as follows:
|  | Years Ended March 31,
|  | 2025 |  | 2024 |  | 2023
Statutory federal income tax rate |  |  | 21.0 | % |  |  | 21.0 | % |  |  | 21.0 | %
State income tax rate, net of federal benefit |  |  | 1.5 | % |  |  | 10.8 | % |  |  | 3.5 | %
Excess tax benefit from share-based compensation |  |  | (1.3 | )% |  |  | (4.8 | )% |  |  | - | %
Foreign income taxed at different rates |  |  | (3.8 | )% |  |  | (9.8 | )% |  |  | (28.7 | )%
Non-deductible debt costs |  |  | (1.2 | )% |  |  | - | % |  |  | - | %
Non-deductible executive compensation |  |  | (2.5 | )% |  |  | (2.6 | )% |  |  | (9.0 | )%
Change in valuation allowance |  |  | (40.1 | )% |  |  | (289.1 | )% |  |  | (25.8 | )%
Uncertain tax positions |  |  | 2.6 | % |  |  | 0.9 | % |  |  | (1.0 | )%
Research and development credit |  |  | 0.6 | % |  |  | 0.7 | % |  |  | 2.7 | %
Other |  |  | (0.9 | )% |  |  | (3.9 | )% |  |  | 2.0 | %
|  |  | (24.1 | )% |  |  | (276.8 | )% |  |  | (35.3 | )%
The Company and its subsidiaries file income tax returns for the U.S. federal, various state, and foreign jurisdictions with varying statutes of limitations. At March 31, 2025, the Company remains subject to examination for fiscal years ended March 31, 2022 and forward. The Company believes no significant changes in the unrecognized tax benefits will occur within the next 12 months. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
|  | Years Ended March 31,
|  |  | 2025 |  |  |  | 2024 |  |  |  | 2023 |
Balance at beginning of period |  | $ | 1,784,000 |  |  | $ | 1,964,000 |  |  | $ | 1,975,000 |
Additions based on tax positions related to the current year |  |  | 53,000 |  |  |  | 15,000 |  |  |  | 53,000 |
Additions for tax positions of prior year |  |  | 43,000 |  |  |  | 15,000 |  |  |  | - |
Reductions for tax positions of prior year |  |  | (518,000 | ) |  |  | (210,000 | ) |  |  | (64,000 | )
Balance at end of period |  | $ | 1,362,000 |  |  | $ | 1,784,000 |  |  | $ | 1,964,000 |
At March 31, 2025, 2024 and 2023, there are $1,112,000, $1,475,000, and $1,616,000, respectively, of unrecognized tax benefits that if recognized would affect the annual effective tax rate. The Company recognizes interest and penalties related to unrecognized tax benefits as part of income tax expense. During the years ended March 31, 2025, 2024, and 2023, the Company recognized interest and penalties of approximately $49,000, $21,000, and $59,000, respectively. The Company had approximately $203,000 and $250,000 for the payment of interest and penalties accrued at March 31, 2025 and 2024, respectively. The Company intends to indefinitely reinvest its undistributed earnings from foreign subsidiaries in foreign operations, with the exception of earnings from its Singapore subsidiary. No incremental U.S. federal tax or withholding taxes have been provided for these earnings.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration